Riverside, CA - This past Wednesday, Riverside Community Hospital's HeartCare Institute celebrated a medical milestone with the successful completion of the 100th Transcatheter Aortic Valve Replacement (TAVR). TAVR is a minimally invasive, life-saving treatment option for patients diagnosed with symptomatic, severe aortic stenosis.
83-year-old Mr. W. Quezada became the 100th patient at Riverside Community Hospital's HeartCare Institute to undergo a TAVR procedure. The 100th TAVR procedure was performed by Syed Bokhari, M.D., F.A.C.C., Interventional Cardiologist and Director of the Structural Heart and TAVR Program.
Riverside Community Hospital performed its first TAVR procedure in December of 2017. Patients who have taken advantage of the TAVR procedure have ranged in age from 65 to 100. The procedure allows a minimally invasive approach to treating a condition known as severe aortic stenosis, a disease that prevents the aortic valve from opening and closing properly, mainly due to age-related calcium build up resulting in narrowing of the main heart valve. TAVR is ideal for symptomatic severe aortic stenosis patients, not only who are deemed to be inoperable or high risk for surgery but also for intermediate risk patients.
"The minimally-invasive TAVR procedure is performed by inserting a hollow tube in the groin and then advancing and replacing the defective aortic valve with the new valve though this tube," explained Dr. Syed Bokhari.
According to the American Heart Association, aortic stenosis is one of the most common and serious valve disease problems affecting nearly 1.5 million people in the United States. Typically, patients present with symptoms of chest pain, shortness of breath, dizziness or passing out and heart failure.
Until recently, the only treatment option was an open-heart surgery. Aortic stenosis is life threatening and the survival rates are only 50% at two years. Aortic stenosis kills more patients than many of the common cancers.
"TAVR now provides patients meeting the clinical criteria a new alternative to traditional open-heart surgery, offering a number of benefits including lower procedural risk, faster recovery time, shorter hospital stay and a better quality of life," added Dr. Syed Bokhari.
"At Riverside Community Hospital we live by our mission: Above all else, we are committed to the care and improvement of human life," said Saba Habis, M.D., Chief Medical Officer at Riverside Community Hospital. "With TAVR, we have been able to offer patients suffering from aortic stenosis more treatment options with great outcomes and faster recovery. Patients who are not candidates for the standard surgical therapy now have the TAVR option. Reaching this milestone successfully is a great testament to the outstanding teamwork of our HeartCare Institute team and commitment of Riverside Community Hospital as we continue to invest in our people, their skills and the latest technology to improve the health of our community."
The HeartCare Institute at Riverside Community Hospital has invested in bringing the latest advanced technology to offer the highest level of quality service to the patients in the region.